MS, Z. S., MD, M. P., MS, L. S., MS, A. F., MS, Y. D., MS, H. G., . . . PhD, Z. X. (2025, March). Comparative Dosimetry and Biological Risk Assessment of Lung Oligometastasis SBRT: VMAT, Helical Tomotherapy, and CyberKnife. Technology in Cancer Research & Treatment.
Chicago Style (17th ed.) CitationMS, Zhenjiong Shen, et al. "Comparative Dosimetry and Biological Risk Assessment of Lung Oligometastasis SBRT: VMAT, Helical Tomotherapy, and CyberKnife." Technology in Cancer Research & Treatment Mar. 2025.
MLA (9th ed.) CitationMS, Zhenjiong Shen, et al. "Comparative Dosimetry and Biological Risk Assessment of Lung Oligometastasis SBRT: VMAT, Helical Tomotherapy, and CyberKnife." Technology in Cancer Research & Treatment, Mar. 2025.
Warning: These citations may not always be 100% accurate.